IR Sant Pau Advances the Development of Fanconinib, a Pioneering Inhibitor Targeting a Key Cancer Pathway
The Sant Pau Research Institute (IR Sant Pau) has received funding from the national “Proof of Concept Projects 2025” call, promoted by the Ministry of Science, Innovation, and Universities throug...